News
As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) ...
As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) remained free ...
20d
News Medical on MSNFirst-of-its-kind technology helps man with ALS ‘speak’ in real timeUC Davis researchers have developed a brain-computer interface that can instantaneously translate brain activity into voice as a person tries to speak — effectively creating a digital vocal tract.
Column - It is easy to claim one is "following the scientific evidence", but what does it mean to actually do so? In his latest #InsideTheBox column, Dr Andy Gray considers how evidence-based health ...
Navigating the Artificial Blood Cells MarketIn the landscape of modern medicine, few innovations hold the transformative ...
The Dark Genome Therapeutics market, valued at USD 2,155.7 million in 2024, is expected to register robust revenue CAGR of 23.8%.Request free copy of this report: 01, 2025 - Integration of AI and ...
Authorship Contributions. JCO Journals adhere to the guidelines on authorship established by the International Committee of Medical Journal Editors (ICMJE) statement on the role of Authors and ...
Meet Emma Rothschild, founder of Bitchin’ Blooms. Learn how she went from a corporate job to a top L.A. floral designer ...
Detailed price information for Envoy Medical Inc (COCH-Q) from The Globe and Mail including charting and trades.
With the June 21 deadline looming, Albuquerque mayoral candidates are in a final push to meet the requirements for ballot ...
Background One-size-fits-all interventions reduce chronic low back pain (CLBP) a small amount. An individualised intervention called cognitive functional therapy (CFT) was superior for CLBP compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results